Blinding in randomized clinical trials: imposed impartiality
Research output: Contribution to journal › Journal article › Research › peer-review
Blinding, or "masking," is a crucial method for reducing bias in randomized clinical trials. In this paper, we review important methodological aspects of blinding, emphasizing terminology, reporting, bias mechanisms, empirical evidence, and the risk of unblinding. Theoretical considerations and empirical analyses support the blinding of patients, health-care providers, and outcome assessors as to the trial intervention to which patients have been allocated. We encourage extensive pretrial testing of blinding procedures and explicit reporting of who was in the blinded condition and the methods used to ensure blinding.
Original language | English |
---|---|
Journal | Clinical Pharmacology and Therapeutics |
Volume | 90 |
Issue number | 5 |
Pages (from-to) | 732-6 |
Number of pages | 5 |
ISSN | 0009-9236 |
DOIs | |
Publication status | Published - 2011 |
ID: 40224683